Literature DB >> 10838454

Diagnosis of granulocytic sarcoma by fine-needle aspiration cytology.

M Bangerter1, A Hildebrand, O Waidmann, M Griesshammer.   

Abstract

Granulocytic sarcoma (GS) occurs in patients with chronic myeloproliferative disorders as well as in patients with acute myeloid leukemia (AML). These tumorous masses can occur anywhere in the body and have to be differentiated from lymphoma, carcinoma or infectious processes. We report the results of fine-needle aspiration cytology (FNAC) in 26 patients with GS. Seventeen patients suffered from AML and 9 from chronic myeloid leukemia (CML) blast crisis. In 5 patients with AML, GS was the initial presentation of hematological malignancy, in the remaining 21 patients, FNAC confirmed relapse of AML or extramedullary blast crisis of CML. In 8 patients, GS was located in the skin, in 17 in the lymph node and in another patient in the spinal canal. This study demonstrates the clinical utility and diagnostic accuracy of FNAC in the evaluation of GS from multiple sites. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2000        PMID: 10838454     DOI: 10.1159/000041028

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  3 in total

1.  Granulocytic sarcoma presenting as an orbital mass: report of two cases.

Authors:  Brijesh Thakur; Kachnar Varma; Vatsala Misra; Smita Chauhan
Journal:  J Clin Diagn Res       Date:  2013-08-01

2.  Cyto-morphological features of extramedullary acute megakaryoblastic leukemia on fine needle aspiration and cerebrospinal fluid cytology: A case report.

Authors:  Sanjeev Chitragar; Shipra Agarwal; Venkateswaran K Iyer; Sandeep R Mathur; Asis K Karak; Taher Chharchhodawala; Atul Sharma; Sameer Bakhshi
Journal:  Cytojournal       Date:  2011-09-27       Impact factor: 2.091

3.  Unusual Presentation of Chronic Myeloid Leukemia in Chronic Phase as Multiple Soft Tissue Chloromas.

Authors:  Sunayana Misra; Kusum Gupta; Preeti Mathur; Poonam Rani
Journal:  J Cytol       Date:  2020-04-02       Impact factor: 1.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.